265 related articles for article (PubMed ID: 19998449)
1. Polymorphisms in the transforming growth factor beta 1 pathway in relation to colorectal cancer progression.
Försti A; Li X; Wagner K; Tavelin B; Enquist K; Palmqvist R; Altieri A; Hallmans G; Hemminki K; Lenner P
Genes Chromosomes Cancer; 2010 Mar; 49(3):270-81. PubMed ID: 19998449
[TBL] [Abstract][Full Text] [Related]
2. Combined genetic assessment of transforming growth factor-beta signaling pathway variants may predict breast cancer risk.
Kaklamani VG; Baddi L; Liu J; Rosman D; Phukan S; Bradley C; Hegarty C; McDaniel B; Rademaker A; Oddoux C; Ostrer H; Michel LS; Huang H; Chen Y; Ahsan H; Offit K; Pasche B
Cancer Res; 2005 Apr; 65(8):3454-61. PubMed ID: 15833881
[TBL] [Abstract][Full Text] [Related]
3. Genetic susceptibility of epidermal growth factor +61A>G and transforming growth factor beta1 -509C>T gene polymorphisms with gallbladder cancer.
Vishnoi M; Pandey SN; Modi DR; Kumar A; Mittal B
Hum Immunol; 2008 Jun; 69(6):360-7. PubMed ID: 18571008
[TBL] [Abstract][Full Text] [Related]
4. Interleukin promoter polymorphisms and prognosis in colorectal cancer.
Wilkening S; Tavelin B; Canzian F; Enquist K; Palmqvist R; Altieri A; Hallmans G; Hemminki K; Lenner P; Försti A
Carcinogenesis; 2008 Jun; 29(6):1202-6. PubMed ID: 18448485
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphism in the transforming growth factor beta1 gene (-509 C/T and -800 G/A) and colorectal cancer.
Amirghofran Z; Jalali SA; Ghaderi A; Hosseini SV
Cancer Genet Cytogenet; 2009 Apr; 190(1):21-5. PubMed ID: 19264229
[TBL] [Abstract][Full Text] [Related]
6. TGFBR1*6A and cancer risk: a meta-analysis of seven case-control studies.
Kaklamani VG; Hou N; Bian Y; Reich J; Offit K; Michel LS; Rubinstein WS; Rademaker A; Pasche B
J Clin Oncol; 2003 Sep; 21(17):3236-43. PubMed ID: 12947057
[TBL] [Abstract][Full Text] [Related]
7. A gain of function TGFB1 polymorphism may be associated with late stage prostate cancer.
Ewart-Toland A; Chan JM; Yuan J; Balmain A; Ma J
Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):759-64. PubMed ID: 15159307
[TBL] [Abstract][Full Text] [Related]
8. Lack of an association between the TGFBR1*6A variant and colorectal cancer risk.
Skoglund J; Song B; Dalén J; Dedorson S; Edler D; Hjern F; Holm J; Lenander C; Lindforss U; Lundqvist N; Olivecrona H; Olsson L; Påhlman L; Rutegård J; Smedh K; Törnqvist A; Houlston RS; Lindblom A
Clin Cancer Res; 2007 Jun; 13(12):3748-52. PubMed ID: 17575241
[TBL] [Abstract][Full Text] [Related]
9. Association of transforming growth factor-beta1 gene polymorphisms with genetic susceptibility to nasopharyngeal carcinoma.
Wei YS; Zhu YH; Du B; Yang ZH; Liang WB; Lv ML; Kuang XH; Tai SH; Zhao Y; Zhang L
Clin Chim Acta; 2007 May; 380(1-2):165-9. PubMed ID: 17368597
[TBL] [Abstract][Full Text] [Related]
10. Genetic variation in transforming growth factor-beta1 gene associated with increased risk of esophageal squamous cell carcinoma.
Wei YS; Xu QQ; Wang CF; Pan Y; Liang F; Long XK
Tissue Antigens; 2007 Dec; 70(6):464-9. PubMed ID: 17990985
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphisms of transforming growth factor-beta1 and its receptors and colorectal cancer susceptibility: a population-based case-control study in China.
Zhang Y; Liu B; Jin M; Ni Q; Liang X; Ma X; Yao K; Li Q; Chen K
Cancer Lett; 2009 Mar; 275(1):102-8. PubMed ID: 19036501
[TBL] [Abstract][Full Text] [Related]
12. The association of the DNA repair gene XRCC3 Thr241Met polymorphism with susceptibility to colorectal cancer in a Chinese population.
Jin MJ; Chen K; Song L; Fan CH; Chen Q; Zhu YM; Ma XY; Yao KY
Cancer Genet Cytogenet; 2005 Nov; 163(1):38-43. PubMed ID: 16271954
[TBL] [Abstract][Full Text] [Related]
13. Resequencing of genes for transforming growth factor beta1 (TGFB1) type 1 and 2 receptors (TGFBR1, TGFBR2), and association analysis of variants with diabetic nephropathy.
McKnight AJ; Savage DA; Patterson CC; Sadlier D; Maxwell AP
BMC Med Genet; 2007 Feb; 8():5. PubMed ID: 17319955
[TBL] [Abstract][Full Text] [Related]
14. [Association of TP53 gene polymorphisms with genetic susceptibility to liver metastases of colorectal cancer].
Wang AZ; Zhu ZZ; Cong WM
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):168-71. PubMed ID: 18393238
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-[beta]1 -509T reduces risk of colorectal cancer, but not adenoma in Koreans.
Chung SJ; Kim JS; Jung HC; Song IS
Cancer Sci; 2007 Mar; 98(3):401-4. PubMed ID: 17214746
[TBL] [Abstract][Full Text] [Related]
16. Association of selected polymorphisms of CCND1, p21, and caspase8 with colorectal cancer risk.
Liu B; Zhang Y; Jin M; Ni Q; Liang X; Ma X; Yao K; Li Q; Chen K
Mol Carcinog; 2010 Jan; 49(1):75-84. PubMed ID: 19795398
[TBL] [Abstract][Full Text] [Related]
17. Analysis of common transforming growth factor beta-1 gene polymorphisms in gastric and duodenal ulcer disease: pilot study.
Polonikov AV; Ivanov VP; Belugin DA; Khoroshaya IV; Kolchanova IO; Solodilova MA; Tutochkina MP; Stepchenko AA
J Gastroenterol Hepatol; 2007 Apr; 22(4):555-64. PubMed ID: 17376051
[TBL] [Abstract][Full Text] [Related]
18. VEGF -460 genotype plays an important role in progression to chronic kidney disease stage 5.
Summers AM; Coupes BM; Brennan MF; Ralph SA; Short CD; Brenchley PE
Nephrol Dial Transplant; 2005 Nov; 20(11):2427-32. PubMed ID: 16046504
[TBL] [Abstract][Full Text] [Related]
19. Regulatory cytokine gene polymorphisms and risk of colorectal carcinoma.
Crivello A; Giacalone A; Vaglica M; Scola L; Forte GI; Macaluso MC; Raimondi C; Di Noto L; Bongiovanni A; Accardo A; Candore G; Palmeri L; Verna R; Caruso C; Lio D; Palmeri S
Ann N Y Acad Sci; 2006 Nov; 1089():98-103. PubMed ID: 17261758
[TBL] [Abstract][Full Text] [Related]
20. A case-control study of childhood acute lymphoblastic leukaemia and polymorphisms in the TGF-beta and receptor genes.
Dai L; Gast A; Horska A; Schrappe M; Bartram CR; Hemminki K; Kumar R; Bermejo JL
Pediatr Blood Cancer; 2009 Jul; 52(7):819-23. PubMed ID: 19229971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
